Harrison Gunn is an associate in the firm’s Litigation Department. He joined Goodwin in 2020. Mr. Gunn focuses his practice on patent matters spanning technologies in the pharmaceutical, electronic and mechanical arts. Mr. Gunn also has experience in assisting with Section 337 Investigations at the International Trade Commission. Mr. Gunn is a contributor to the firm’s Big Molecule Watch, an award-winning blog that reports real-time analysis and updates on regulatory issues, litigation, legislation, and other news in the developing world of biosimilars.
Professional Experience
In law school, Mr. Gunn assisted clients with biotechnology and nanotechnology related products through the Detkin Intellectual Property and Technology Legal Clinic. He was also an editor of the Journal of Law & Innovation and the Journal of Business Law and was a President of the Penn Intellectual Property Group. Mr. Gunn received a Certificate in Engineering Entrepreneurship from the School of Engineering and Applied Science at the University of Pennsylvania concurrent with his legal studies.
Credentials
Education
JD2020
University of Pennsylvania Law School
(cum laude)
BSChemical Engineering2017
Syracuse University
(summa cum laude)
Admissions
Bars
- Massachusetts